Discovery Accelerated

Drug Development and Outcome Measures in Eosinophilic Esophagitis (EoE)

View Now

Register now and you will receive a link to view the video of the event.

Event Date

Recorded on June 22, 2021 From 1:00 – 2:00 pm EDT

Event Details

Join our panel of experts for presentations and discussion on drug development and outcome measures in eosinophilic esophagitis (EoE)

About This Event

Swallowed topical corticosteroids and proton pump inhibitors have historically been the mainstays of medical therapy for EoE. Several new classes of treatment are now in development and the therapeutic landscape is anticipated to change drastically over the next decade.

Presentations from our experts will span basic science to clinical trials covering topics including:

  • An overview of current and future therapeutic targets in EoE
  • Advancements in existing EoE drug development programs
  • The evolution in assessment of endoscopic and histologic disease activity in EoE
  • The importance of patient-reported outcomes in EoE
  • The pipeline for drug development in EoE

Expert Panel

Arjan Bredenoord MD, PhD
Arjan Bredenoord MD, PhD
AMC, Amsterdam, Netherlands

Dr. Albert J (Arjan) Bredenoord studied Medicine in Antwerp, Belgium. He subsequently worked on several… Read More

Evan S. Dellon MD, MPH
Evan S. Dellon MD, MPH
UNC-Chapel Hill, North Carolina

Evan S. Dellon, MD, MPH, is a Professor of Medicine and Adjunct Professor of Epidemiology at the University of North… Read More

Ekaterina Safroneeva, PhD, PD
Ekaterina Safroneeva, PhD, PD
Senior Researcher
University of Bern, Switzerland

The objective of her research is to study outcome assessment in adults with eosinophilic esophagitis (EoE)… Read More

Christopher Ma, MD<br>
Christopher Ma, MD
Senior Medical Director
Alimentiv Inc.

Dr. Ma obtained his MD from the University of Calgary in 2012. He completed his Internal Medicine residency at the University of Alberta… Read More